First Trust Advisors LP Ampio Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $553,080 - $822,763	-457,091 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $25,499 - $32,365	-16,346 Reduced 3.45%	457,091 $763,000
Q1 2021 May 14, 2021	BUY	$1.36 - $2.49 $83,688 - $153,224	61,536 Added 14.94%	473,437 $800,000
Q4 2020 Feb 02, 2021	BUY	$0.75 - $2.76 $891 - $3,278	1,188 Added 0.29%	411,901 $655,000
Q3 2020 Nov 05, 2020	BUY	$0.61 - $1.17 $250,534 - $480,534	410,713 New	410,713 $393,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.